EirGenix Inc.
EirGenix Inc. operates as a contract development and manufacturing company in Taiwan and internationally. The company offers cell line development, process development, analytical and quality control, cGMP manufacturing mammalian and microbial system, and antibody-drug conjugate services. It is also involved in the development of EG12014/EGI014, a Trastuzumab biosimilar, indicated for the treatme… Read more
EirGenix Inc. (6589) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.004x
Based on the latest financial reports, EirGenix Inc. (6589) has a cash flow conversion efficiency ratio of -0.004x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-34.81 Million) by net assets (NT$8.44 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
EirGenix Inc. - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how EirGenix Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
EirGenix Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of EirGenix Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BANDWID.INC. CL.A DL-001
F:5XB
|
N/A |
|
Nano Dimension Ltd
NASDAQ:NNDM
|
-0.013x |
|
POWERFLEET INC. DL-01
F:3LO
|
N/A |
|
Kossan Rubber Industries Bhd
PINK:KSRBF
|
0.031x |
|
Longjian Road & Bridge Co Ltd
SHG:600853
|
0.111x |
|
Orange County Bancorp Inc
NASDAQ:OBT
|
0.106x |
|
JINS HOLDINGS INC.
F:5F3
|
N/A |
|
Blue Dart Express Limited
NSE:BLUEDART
|
0.165x |
Annual Cash Flow Conversion Efficiency for EirGenix Inc. (2021–2024)
The table below shows the annual cash flow conversion efficiency of EirGenix Inc. from 2021 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$9.26 Billion | NT$-311.44 Million | -0.034x | +60.29% |
| 2023-12-31 | NT$10.02 Billion | NT$-848.56 Million | -0.085x | -513.43% |
| 2022-12-31 | NT$10.68 Billion | NT$-147.52 Million | -0.014x | -381.65% |
| 2021-12-31 | NT$10.43 Billion | NT$-29.90 Million | -0.003x | -- |